Wealthcare Advisory Partners LLC Vertex Pharmaceuticals Inc Transaction History

Wealthcare Advisory Partners LLC

$3.43 Billion
Q3 2024

A detailed history of Wealthcare Advisory Partners LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Wealthcare Advisory Partners LLC holds 3,089 shares of VRTX stock, worth $1.45 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,089

Previous 3,328 7.18%

Holding current value

$1.45 Million

Previous $1.56 Million 7.89%

% of portfolio

0.04%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$460.0 - $505.78 $109,940 - $120,881	-239 Reduced 7.18%	3,089 $1.44 Million
Q2 2024 Aug 09, 2024	BUY	$392.81 - $485.53 $43,209 - $53,408	110 Added 3.42%	3,328 $1.56 Million
Q1 2024 Apr 15, 2024	BUY	$407.69 - $446.08 $57,484 - $62,897	141 Added 4.58%	3,218 $1.35 Million
Q4 2023 Feb 06, 2024	SELL	$343.0 - $410.68 $14,063 - $16,837	-41 Reduced 1.31%	3,077 $1.25 Million
Q3 2023 Oct 12, 2023	SELL	$338.18 - $362.46 $11,159 - $11,961	-33 Reduced 1.05%	3,118 $1.08 Million
Q2 2023 Jul 17, 2023	SELL	$314.42 - $351.91 $65,399 - $73,197	-208 Reduced 6.19%	3,151 $1.11 Million
Q1 2023 May 04, 2023	SELL	$283.23 - $323.1 $25,773 - $29,402	-91 Reduced 2.64%	3,359 $1.06 Million
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $26,004 - $29,254	91 Added 2.71%	3,450 $996,000
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $42,717 - $47,662	156 Added 4.87%	3,359 $973,000
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $66,023 - $82,206	-281 Reduced 8.07%	3,203 $903,000
Q1 2022 Apr 15, 2022	SELL	$221.42 - $260.97 $31,220 - $36,796	-141 Reduced 3.89%	3,484 $909,000
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $386,766 - $488,238	2,185 Added 151.74%	3,625 $796,000
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $1,088 - $1,217	6 Added 0.42%	1,440 $261,000
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $6,187 - $7,296	33 Added 2.36%	1,434 $289,000
Q1 2021 Apr 30, 2021	BUY	$207.02 - $241.31 $290,035 - $338,075	1,401 New	1,401 $301,000
Q2 2020 Jul 29, 2020	SELL	$225.48 - $295.8 $24,126 - $31,650	-107 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$199.77 - $247.81 $799 - $991	4 Added 3.88%	107 $25,000
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $454 - $531	-3 Reduced 2.83%	103 $17,000
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $411 - $466	3 Added 2.91%	106 $16,000
Q3 2017 Nov 15, 2017	BUY	$148.13 - $162.24 $15,257 - $16,710	103	103 $16,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.

Account

Wealthcare Advisory Partners LLC Vertex Pharmaceuticals Inc Transaction History